CODY WILLIAMS: Open Payments
NPI 1124651468 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,607 in 131 payments from 44 companies in 2025. Trend: 2023 $2,438 · 2024 $2,523 · 2025 $2,607
Food & beverage: $2,386Education: $221
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $214 |
| AstraZeneca Pharmaceuticals LP | 9 | $193 |
| Celgene Corporation | 16 | $185 |
| Novartis Pharmaceuticals Corporation | 9 | $183 |
| Gilead Sciences, Inc. | 4 | $150 |
| GENZYME CORPORATION | 5 | $139 |
| Merck Sharp & Dohme LLC | 8 | $135 |
| Janssen Biotech, Inc. | 5 | $104 |
| BeOne Medicines USA, Inc. | 5 | $92 |
| GlaxoSmithKline, LLC. | 5 | $92 |
Products named: ENHERTU, REBLOZYL, Trodelvy, AYVAKIT, KEYTRUDA, BRUKINSA, PLUVICTO, JAKAFI.
Industry payments across AR — which companies pay providers there.
